Ceftobiprole medocaril

Mabelio

Polvere per concentrato per soluzione per infusioneItalyAuthorised

In other countries

The same active substances on other registers, the same brand first.

Zevtera 500 MG Polvo Para Concentrado Para Solucion Para PerfusionSpain · 666.6 mg · polvo para concentrado para solución para perfusión · Advanz Pharma LimitedSame form
ZEVTERA 500 mg Powder for concentration for Solution for InfusionSaudi Arabia · Nipro Pharma Corporation Ise PlantSame form
ZevteraBrazil · United Medical LtdaSame substance
ZevteraCanada · 500 MG / VIAL · Powder For Solution · Avir Pharma INC.Same substance
ZefteraCanada · 500 MG / VIAL · Powder For Solution · Janssen INCSame substance
Zeftera (previously Zevtera)European Union · Janssen-Cilag International NVSame substance

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Ceftobiprole medocaril

Mabelio

Polvere per concentrato per soluzione per infusioneItalyAuthorised

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Zevtera

United States · 667MG/VIAL · powder · Istx

Packs

Pack	Code	Status
500 MG POLVERE PER CONCENTRATO PER SOLUZIONE PER INFUSIONE- 10 FLACONCINI IN VETRO DA 20 ML	043060019	Autorizzata

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Ceftobiprole medocaril
Dosage form: Polvere per concentrato per soluzione per infusione
Register: Italy (AIFA)
Status: Authorised
Status in the register: Autorizzata
Registration: AIC 043060
Marketing authorisation holder: Advanz Pharma Limited
ATC code: J01DI01
Group: Anti-infectives for systemic use
Procedure: Procedura Mutuo riconoscimento o Decentrata
Supply: Medicinali soggetti a prescrizione medica limitativa, utilizzabili esclusivamente in ambiente ospedaliero o in una struttura ad esso assimilabile